DAK HEALTH has floated a tender for Completion of a Non -exclusive Discount Agreement According to Section 130a (8) Sgb V on the Active Ingredient Ranibizumab, Atc S01la04 for the Time 01.09.2022 - 31.08.2023 (plus Extension Option 1x12 Months). The project location is Germany and the tender is closing on 05 Jul 2024. The tender notice number is -, while the TOT Ref Number is 69242187.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Completion of a Non -exclusive Discount Agreement According to Section 130a (8) Sgb V on the Active Ingredient Ranibizumab, Atc S01la04 for the Time 01.09.2022 - 31.08.2023 (plus Extension Option 1x12 Months)